首页> 外文期刊>Journal of Clinical Microbiology >T-cell subpopulations, expression of interleukin-2 receptor, and production of interleukin-2 and gamma interferon in human American cutaneous leishmaniasis.
【24h】

T-cell subpopulations, expression of interleukin-2 receptor, and production of interleukin-2 and gamma interferon in human American cutaneous leishmaniasis.

机译:T细胞亚群,白细胞介素-2受体的表达,以及在人类皮肤无山病中的白细胞介素-2和γ干扰素的产生。

获取原文
           

摘要

Leukocyte subpopulations, the expression of the interleukin-2 (IL-2) receptor, and the production of IL-2 and gamma interferon (IFN-gamma) were studied in the peripheral blood mononuclear cells of American cutaneous leishmaniasis patients that had been stimulated in vitro with either leishmanial antigen or mitogen (phytohemagglutinin M). The 75 patients examined were classified as having either the localized (LCL; 66 patients), mucocutaneous (MCL; 5 patients), or the rare diffuse (DCL; 4 patients) form of the disease. Patients with DCL, who are characterized by their defective cell-mediated immune response to leishmanial antigen, failed to express the IL-2 receptor and did not produce IFN-gamma when exposed to the antigen but did so when stimulated by phytohemagglutinin M. Both LCL and MCL patients showed strong proliferative responses to leishmanial antigen; these were by far the greatest in MCL patients. Both groups had significantly increased IL-2 receptor expression and IFN-gamma production after exposure to either antigen or mitogen, and these were highest in the MCL patients. Concerning the leukocyte subpopulations evaluated (CD2, CD4, CD8, CD20, MO2), the most significant findings were a decrease of both CD4+ cells and the CD4/CD8 ratio in MCL patients compared with the other groups. Considering IL-2 production, in response to phytohemagglutinin M both MCL and LCL patients showed amounts of IL-2 comparable to those of the controls. Our results help explain the anergy of T cells from DCL patients to leishmanial antigen, which could lead to a defective production of IFN-gamma and possibly contribute to their incapacity to kill the Leishmania parasite. Concerning MCL patients, the significantly increased expression of IL-2 receptor, decreased expression of the CD4 (helper-inducer of suppression) phenotype, and elevated IFV-gamma production might partially explains the state of hypersensitivity and mucosal damage exhibited by these patients.
机译:白细胞凋亡,白细胞介素-2(IL-2)受体的表达,以及IL-2和γ干扰素(IFN-Gamma)的产生,在美国皮肤皮肤的外周血单核细胞中受到刺激的与利什曼抗原或丝分裂原(Phytohemagglutinin m)的体外。检查的75名患者被归类为局部化(LCL; 66名患者),粘膜皮下(MCL; 5名患者),或罕见的弥漫(DCL; 4患者)形式的疾病。 DCL的患者,其特征在于它们对LeishManial抗原的细胞介导的免疫应答的缺陷,未能表达IL-2受体,并且在暴露于抗原时不会产生IFN-γ,但是当由PhytohemagglutininM.刺激时,LCL刺激和MCL患者对LeishManial抗原的增殖性反应有很强的增殖反应;这些是MCL患者中最伟大的。在暴露于抗原或丝分裂原后,两组在接触后显着增加了IL-2受体表达和IFN-Gamma生产,并且在MCL患者中最高。关于评估的白细胞亚流量(CD2,CD4,CD8,CD20,MO 2),与其他基团相比,最重要的发现是CD4 +细胞和MCL患者中的CD4 / CD8比率降低。考虑到IL-2生产,响应于PhytohemagglutininM MCL和LCL患者显示与对照组相当的IL-2的量。我们的结果有助于将DCL患者的T细胞的毒品解释为LeishManial抗原,这可能导致IFN-Gamma的缺陷生产,并且可能导致他们丧失杀死Leishmania寄生虫的干扰。关于MCL患者,IL-2受体的显着增加,降低CD4(抑制的辅助诱导症)表型表达,升高的IFV-Gamma产量可能部分地解释了这些患者表现出的过敏性和粘膜损伤的状态。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号